These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 6870913)
1. The effect of diaminoalkyl-anthraquinone derivatives on the growth of the promastigotes of Leishmania tropica minor, L. t. major, L. donovani and L. aethiopica. Schnur L; Bachrach U; Bar-Ad G; Haran M; Tashma Z; Talmi M; Katzhendler J Biochem Pharmacol; 1983 Jun; 32(11):1729-32. PubMed ID: 6870913 [TBL] [Abstract][Full Text] [Related]
2. Synthesis of a small library of 2-phenoxy-1,4-naphthoquinone and 2-phenoxy-1,4-anthraquinone derivatives bearing anti-trypanosomal and anti-leishmanial activity. Bolognesi ML; Lizzi F; Perozzo R; Brun R; Cavalli A Bioorg Med Chem Lett; 2008 Apr; 18(7):2272-6. PubMed ID: 18353643 [TBL] [Abstract][Full Text] [Related]
3. Chemotherapeutic activity of rifampicin on leishmanial amastigotes and promastigotes in vitro. El-On J; Pearlman E; Schnur LF; Greenblatt CL Isr J Med Sci; 1983 Mar; 19(3):240-5. PubMed ID: 6853121 [TBL] [Abstract][Full Text] [Related]
4. Antileishmanial activity of a new 8-hydroxyquinoline derivative designed 7-[5'-(3'-phenylisoxazolino)methyl]-8-hydroxyquinoline: preliminary study. Dardari Z; Lemrani M; Bahloul A; Sebban A; Hassar M; Kitane S; Berrada M; Boudouma M Farmaco; 2004 Mar; 59(3):195-9. PubMed ID: 14987982 [TBL] [Abstract][Full Text] [Related]
5. Identification of chalcone-based antileishmanial agents targeting trypanothione reductase. Ortalli M; Ilari A; Colotti G; De Ionna I; Battista T; Bisi A; Gobbi S; Rampa A; Di Martino RMC; Gentilomi GA; Varani S; Belluti F Eur J Med Chem; 2018 May; 152():527-541. PubMed ID: 29758517 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of Thiocarbohydrazones and Evaluation of their in vitro Antileishmanial Activity. Muhammad MT; Ghouri N; Khan KM; Arshia ; Choudhary MI; Perveen S Med Chem; 2018; 14(7):725-732. PubMed ID: 29332596 [TBL] [Abstract][Full Text] [Related]
7. The effect of cicerfuran, an arylbenzofuran from Cicer bijugum, and related benzofurans and stilbenes on Leishmania aethiopica, L. tropica and L. major. Getti GT; Aslam SN; Humber DP; Stevenson PC; Cheke RA Planta Med; 2006 Aug; 72(10):907-11. PubMed ID: 16902862 [TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo anti-leishmanial activity of chlorpromazine alone and combined with N-meglumine antimonate. el-On J; Rubinstein N; Kernbaum S; Schnur LF Ann Trop Med Parasitol; 1986 Oct; 80(5):509-17. PubMed ID: 3632098 [TBL] [Abstract][Full Text] [Related]
9. Anti-parasite activity of nucleoside analogues: the metabolism of carbocyclic inosine in promastigotes of Leishmania tropica and Leishmania donovani and its activity against amastigotes of Leishmania donovani in vitro. Wataya Y; Satake H; Hiraoka O; Aji T; Morishige K; Kimura JY; Ishii A; Matsuda A; Ueda T; Fukukawa K Nucleic Acids Symp Ser; 1986; (17):149-51. PubMed ID: 3562260 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vitro antileishmanial efficacy of novel quinazolinone derivatives. Prinsloo IF; Zuma NH; Aucamp J; N'Da DD Chem Biol Drug Des; 2021 Feb; 97(2):383-398. PubMed ID: 32914553 [TBL] [Abstract][Full Text] [Related]
11. Polyamines and the growth of leishmanial parasites. Bachrach U; Abu-Elheiga L; Talmi M; Schnur LF; El-On J; Greenblatt CL Med Biol; 1981 Dec; 59(5-6):441-7. PubMed ID: 7339304 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of New Cyclic Imides Derived from Safrole, Structure- and Ligand-based Approaches to Evaluate Potential New Multitarget Agents Against Species of Leishmania. de Sousa Luis JA; da Silva Costa NA; Luis CCS; Lira BF; Athayde-Filho PF; de Souza Lima TK; da Câmara Rocha J; Scotti L; Scotti MT Med Chem; 2020; 16(1):39-51. PubMed ID: 31208311 [TBL] [Abstract][Full Text] [Related]
13. Antileishmanial activity of polycyclic derivatives. Sarciron ME; Terreux R; Prieto Y; Cortes M; Cuellar MA; Tapia RA; Domard M; Walchshofer N; Pétavy AF Parasite; 2005 Sep; 12(3):251-8. PubMed ID: 16218213 [TBL] [Abstract][Full Text] [Related]
14. In vitro growth inhibitory activity of Medicines for Malaria Venture pathogen box compounds against Leishmania aethiopica. Tadele M; Abay SM; Asaga P; Makonnen E; Hailu A BMC Pharmacol Toxicol; 2021 Nov; 22(1):71. PubMed ID: 34784983 [TBL] [Abstract][Full Text] [Related]
15. Inhibition by Dications of in vitro growth of Leishmania major and Leishmania tropica: causative agents of old world cutaneous leishmaniasis. Rosypal AC; Werbovetz KA; Salem M; Stephens CE; Kumar A; Boykin DW; Hall JE; Tidwell RR J Parasitol; 2008 Jun; 94(3):743-9. PubMed ID: 18605790 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and antileishmanial activity of novel pyridinium-hydrazone derivatives. Alptuzun V; Cakiroglu G; Limoncu ME; Erac B; Hosgor-Limoncu M; Erciyas E J Enzyme Inhib Med Chem; 2013 Oct; 28(5):960-7. PubMed ID: 22803671 [TBL] [Abstract][Full Text] [Related]
17. In vitro Antileishmanial Activity of Some Ethiopian Medicinal Plants. Nigatu H; Belay A; Ayalew H; Abebe B; Tadesse A; Tewabe Y; Degu A J Exp Pharmacol; 2021; 13():15-22. PubMed ID: 33488126 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of trifluralin analogues as antileishmanial agents. Esteves MA; Fragiadaki I; Lopes R; Scoulica E; Cruz ME Bioorg Med Chem; 2010 Jan; 18(1):274-81. PubMed ID: 19926293 [TBL] [Abstract][Full Text] [Related]
19. Effects of thiastearic acids on growth and on dihydrosterculic acid and other phospholipid fatty acyl groups of Leishmania promastigotes. Beach DH; Pascal RA; Holz GG Mol Biochem Parasitol; 1989 Jun; 35(1):57-66. PubMed ID: 2761573 [TBL] [Abstract][Full Text] [Related]
20. A tissue culture system for the growth of several species of Leishmania: growth kinetics and drug sensitivities. Martinez S; Looker DL; Marr JJ Am J Trop Med Hyg; 1988 Mar; 38(2):304-7. PubMed ID: 2833127 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]